Survey of Hepatitis B Vaccination Coverage and Surface Antibody–Positive Rates in People Aged 1–59 Years in 2006 and 2024
Open Forum Infectious Diseases · 27.09.2024 · 11 (10)
DOI: 10.1093/ofid/ofae589 ↗Kurz gefasst
Fachartikel in der Zeitschrift Open Forum Infectious Diseases, online erschienen am 05.10.2024. Verfasst von Xiaoying Gong und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunity, Quzhou Center for Disease Control and Prevention, Quzhou, Zhejiang, China. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Clinical Research Application Project, Zhejiang Health Science and Technology, Hepatitis B Prevention and Control Research Foundation of China.
Abstract (Originalsprache)
Background
Implementing hepatitis B vaccination is an important strategy to reduce hepatitis B virus infection and disease burden. Suboptimal adult hepatitis B vaccination coverage limits the further reduction of hepatitis B virus infection.
Methods
A multistage stratified random sampling method was adopted to survey the permanent population aged 1–59 in 2006 and 2024. We calculated the vaccination coverage rate, hepatitis B surface antibody (HBsAb)–positive rate, rate difference, and their 95% confidence intervals (CIs) of the 2 survey populations, and used the 95% CI and χ2 test to determine whether the difference in rate was statistically significant.
Results
Six hundred twenty-three people were surveyed in 2006 and 606 people were surveyed in 2024. From 2006 to 2024, the hepatitis B vaccination coverage among people aged 1–59 years increased from 54.1% to 78.9%, and the HBsAb-positive rate increased from 46.2% to 57.6%. There was no significant difference in vaccination coverage in the population <15 years of age, but the antibody-positive rate increased significantly. The vaccination coverage rate of the 15–59 age group increased significantly, but there was no statistical difference in the antibody positivity rate of the 15–49 age group, and the antibody positivity rate of the 50–59 age group increased significantly.
Conclusions
Hepatitis B vaccination coverage among adults was still insufficient. Hepatitis B vaccine-mediated immunity was low in adults aged 30–49 years. It is recommended to update the guidelines for hepatitis B vaccination of adults in China, cancel the assessment of risk factors and prevaccination serological screening, and emphasize universal vaccination of all unvaccinated adults to increase coverage.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Immunity, Quzhou Center for Disease Control and Prevention, Quzhou, Zhejiang, China.
ORCID-Profile: Xiaoying Gong, Zhiying Yin
Förderung
- Clinical Research Application Project
- Zhejiang Health Science and Technology
- Hepatitis B Prevention and Control Research Foundation of China
Zitieren
APA
Gong, X., Zheng, C., Fang, Q., Xu, W., & Yin, Z. (2024). Survey of Hepatitis B Vaccination Coverage and Surface Antibody–Positive Rates in People Aged 1–59 Years in 2006 and 2024. Open Forum Infectious Diseases, 11(10). https://doi.org/10.1093/ofid/ofae589
Vancouver
Gong X, Zheng C, Fang Q, Xu W, Yin Z. Survey of Hepatitis B Vaccination Coverage and Surface Antibody–Positive Rates in People Aged 1–59 Years in 2006 and 2024. Open Forum Infectious Diseases. 2024;11(10). doi:10.1093/ofid/ofae589
BibTeX
@article{Gong2024,
author = {Gong, Xiaoying and Zheng, Canjie and Fang, Quanjun and Xu, Wenjie and Yin, Zhiying},
title = {Survey of Hepatitis B Vaccination Coverage and Surface Antibody–Positive Rates in People Aged 1–59 Years in 2006 and 2024},
journal = {Open Forum Infectious Diseases},
year = {2024},
volume = {11},
number = {10},
doi = {10.1093/ofid/ofae589}
}
EUVIMED